Financing in Biological Technology

Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors

PALO ALTO, Calif., July 21 /PRNewswire/ -- Signostics Inc., a U.S. and Australian-based medical device company developing groundbreaking personal ultrasound devices, announced today it has raised US$4 million in its latest round of financing, including new investments from Australian-bas...

Oxygen Biotherapeutics, Inc. Announces Closing of Private Placement Financing Agreement

COSTA MESA, Calif., July 16 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bullletin Board: OXBO) today announced that the company has closed on the first $5 million financing tranche with the Vatea Fund, Segregated Portfolio under a June 8, 2009 securities purchase agr...

NovImmune Completes CHF 62.5 (USD 54.8) Million Equity Financing to Move Portfolio Forward and Reacquire Product Rights to Lead Antibodies

PLAN-LES-OUATES, Switzerland, May 12 /PRNewswire/ -- NovImmune, an immunology-focused biotech company dedicated to the development of therapeutic monoclonal antibodies, announced today that it has raised CHF 62.5 million (USD 54.8 million) to take back control of its lead compounds (NI-0401 an...

ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG

OAKWOOD VILLAGE, Ohio, April 14 /PRNewswire/ -- ViewRay Incorporated, a medical device company, announces the close of the second tranche of their $25M Series B financing. Funding was triggered by the company's achievement of a major milestone towards the development of their image guided cancer t...

NeoStem Completes $11 Million Private Placement Financing to Support Expansion Activities in China, Further Development of NeoStem's VSEL Technology and Advancement of Medical Tourism Initiatives

NEW YORK, April 13 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS ) announced today that it has completed a private placement financing totaling $11 million from three Asia-based investors, including a private equity firm operating in partnership with strategic investors drawn from leading A...

Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million

SAN DIEGO, March 23 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today it has obtained an equity financing commitment of up to $50 million from Azimuth Opportunity Ltd. During the 18-month term of the equity financing commitment, Arena may sell newly issued reg...

VIA Pharmaceuticals Secures Financing Up to $10.0 Million

SAN FRANCISCO, March 12 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced it has entered into a $10.0 million secured note purchase agreem...

GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners

SCHLIEREN, Switzerland, March 5 /PRNewswire/ -- - Proceeds to Facilitate Clinical Development of Lead Conjugate Vaccine GlycoVaxyn, a pioneer in the development of innovative conjugated vaccines, today announced the successful closing of a CHF25 million (ca. US$22 million, EUR17 ...

BioMed Realty Trust Announces New Financing for Joint Venture With Prudential Real Estate Investors

SAN DIEGO, Feb. 11 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR ) announced today the completion of a refinancing of the secured acquisition and interim loan facility originally entered into in April 2007 by its joint venture with a fund managed by Prudential Real Estate Invest...

Bion Announces PENNVEST Board Approves $7.8 Million Financing for Kreider Farms Dairy Project

NEW YORK, Jan. 28 /PRNewswire-FirstCall/ -- Bion Environmental Technologies, Inc. (OTC Bulletin Board: BNET) announced today that on Monday, January 26, 2009, the Pennsylvania Infrastructure Investment Authority (PENNVEST) approved a $7.8 million loan to Bion PA 1, LLC (a wholly-owned subsidiary...

Singulex Closes $19 Million Financing Round

ALAMEDA, Calif., Jan. 12 /PRNewswire/ -- Singulex, Inc. today announced that it has closed a $19 million financing round, led by JAFCO Co., Ltd. and supported by existing investors including OrbiMed Advisors and Fisk Ventures. The financing round will support the commercialization of Singulex tech...

Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer

TORONTO, Dec. 9 /PRNewswire/ - Interface Biologics Inc. - a privately held developer of novel biomedical-polymers for use in implantable medical devices - is announcing that it has secured a $5mm financing round. Participating in the round were existing investors Covington Capital, VG Partners and...

Avantium Completes EUR 18 Million Financing Round

AMSTERDAM, October 29 /PRNewswire/ -- Avantium announced today the successful completion of a EUR 18 million private financing round. Avantium is active in the development and commercialization of Furanics, Avantium's next generation biofuel and bioplastic, and the improvement of pharmaceutica...

NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.

NeoStem Opens New Boston Area Facility NEW YORK, Oct. 27 /PRNewswire-FirstCall/ -- NeoStem, Inc. (AMEX: NBS - News), NeoStem, Inc., which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today that it has closed...

Golub Capital Provides Debt Financing to Support the Acquisition of DNA Diagnostics Center, Inc. by MTS Health Investors, LLC

NEW YORK, Oct. 21 /PRNewswire/ -- Golub Capital today announced that it has provided a GOLD facility for the acquisition of DNA Diagnostics Center, Inc. (DDC) by MTS Health Investors, LLC (MTS). GOLD financings are proprietary Golub Capital One-Loan Debt facilities. Terms of the transaction we...

Sensorin Raises Equity Financing to Launch Novel Industrial Sensing Venture

BURLINGAME, Calif., Oct. 21 /PRNewswire/ -- Sensorin, which is developing and commercializing a novel self-calibrating pH measurement platform for bioprocess applications, today announced the closing of its second round of equity funding. Use of proceeds from the financing includes product dev...

China Bio Energy Holdings Group Announces Financing and Exercise of Warrants

--Receives Proceeds of $14.1 million-- XI'AN, China, Oct. 16 /Xinhua-PRNewswire-FirstCall/ -- China Bio Energy Holdings (OTC Bulletin Board: CBEH) ("China Bio Energy" and the "Company"), an energy company engaged in the distribution of heavy oil and finished oil products and t...

Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway

TORONTO, Sept. 18 /PRNewswire/ - Trillium Therapeutics Inc., a privately-held biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune-mediated disorders, announced today that it has secured $12 million in new financing from its existing inv...

Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director

Clinical Trial Programs Funded Through 2009 SAN FRANCISCO, Sept. 9 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biopharmaceutical company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announ...

Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group

- These funds will be used to rapidly implement the first phase of the production capacity and productivity expansion in order to meet strongly increasing customer demand- - No more concerns about raising additional capital now- - The Company has decided not to proceed with the priva...

Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute

- Results in Proceeds of $2.0 Million - MONTVALE, N.J., Aug. 26 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) today announced that it has secured $2.0 million through the sale of approximately 4.7 million shares of common stock at $0.42 per share under its June 2007...

TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm

NEW YORK, MUNICH, Germany and AMSTERDAM, Netherlands, Aug. 21 /PRNewswire/ -- Paul Capital Healthcare and SpePharm Holding, B.V., the pan-European specialty pharmaceutical company, today announced that they have entered into a euro 10 million revenue interest acquisition financing agreement to...

Novavax Announces Pricing of $18 Million Financing of Common Stock and Warrants

ROCKVILLE, Md., July 29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) today announced the pricing of a registered direct equity financing of $18 million by issuing common stock and warrants from its existing shelf registration. The Company has entered into subscription agreements wi...

Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors

REDWOOD CITY, Calif., July 2 /PRNewswire/ -- Pearl Therapeutics, Inc., a biopharmaceutical company developing products for major respiratory diseases, today announced that it has completed the closing of an $18 million round of financing. This financing was executed as an extension to its firs...

MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures

Pioneer in Centralized Psychiatric Patient Evaluation for Clinical Trials Expanding Into New Areas of Drug Development HAMILTON, N.J., July 1 /PRNewswire/ -- MedAvante, Inc., the leader in centralized psychiatric patient evaluation, announced today that it has closed a $20 million ...

Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs

BERKELEY HEIGHTS, N.J., June 5 /PRNewswire-FirstCall/ --Genta Incorporated (OTC Bulletin Board: GNTA) announced today that the Company has entered into definitive agreements with institutional and accredited investors to place Senior Secured Convertible Notes due 2010 totaling in aggregate up ...

NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center

NEW YORK, May 21 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, today announced a private placement financing in a total amount of $900,000, which includes a st...

Novasys Medical Secures $49.5 Million in Series D Financing to Expand Commercialization of Its Renessa(R) Treatment for Incontinence in Women

NEWARK, Calif., May 15 /PRNewswire/ -- Novasys Medical, Inc., a developer of innovative therapies in women's health, announced today that it has secured $49.5 million in Series D preferred stock financing. The round was led by Versant Ventures, with ThreeArch Partners and Skyline Ventures also...

Cohera Medical, Inc. Announces Closing of Insider Round of Financing for Over $7.6 Million

PITTSBURGH, May 7 /PRNewswire/ -- Cohera Medical, Inc., a rapidly growing medical device company developing a suite of wound management systems and surgical adhesives, announced today that it has closed an insider round of financing for over $7.6 Million. The proceeds of this transaction will ...

Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share

ARLINGTON, Va., April 23 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, announced today the completion of a $2,500,000 pri...

Biofisica Obtains $2.3 Million in Financing From Investors

ATLANTA, April 21 /PRNewswire/ -- Biofisica Inc., an Atlanta-based company specializing in wound care therapy, today announced that it has obtained a commitment of $2.3 million in financing from investors. The funding will support Biofisica's continued marketing efforts in the UK and ongoing p...

Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement

NEW YORK and WINNERSH, England, April 21 /PRNewswire/ -- Paul Capital Healthcare and Vernalis plc (LSE: VER) today announced that they have signed a financing agreement relating to frovatriptan, Vernalis' product for the treatment of migraine. Under the agreement, Vernalis will receive approxi...

REVISED: BrainCells Inc. Expands Series B Financing to $50 Million

SAN DIEGO, April 17 /PRNewswire/ -- BrainCells Inc. (BCI), a biopharmaceutical company utilizing its platform technology to identify and develop compounds that promote the growth of new neurons for the treatment of central nervous system (CNS) diseases, announced today that it raised an additi...

BrainCells Inc. Expands Series B Financing to $50 Million

SAN DIEGO, April 17 /PRNewswire/ -- BrainCells Inc. (BCI), a biopharmaceutical company utilizing its platform technology to identify and develop compounds that promote the growth of new neurons for the treatment of central nervous system (CNS) diseases, announced today that it raised an additi...

Plethora and Paul Capital Healthcare sign a $25 million revenue interest financing agreement with an option for an additional $3 million equity investment

LONDON, April 1, 2008 /PRNewswire/ -- Plethora Solutions Holdings PLC ("Plethora", AIM: PLE), the developer of specialist products for the treatment and management of urological disorders, today announced that it has entered into a revenue interest financing agreement with Paul Capital Healthc...

Modigene Announces Closing of $12 Million Financing by Members of The Frost Group

- Financing Includes Equity Investment and Line of Credit - NES-ZIONA, Israel, March 27 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG), a biopharmaceutical company applying its patented technology to develop longer-acting versions of already-approved therapeutic prote...

Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round

New Investment Round Led by OrbiMed Advisors, World's Largest Healthcare Investment Firm FREISING-WEIHENSTEPHAN, Germany, March 27 /PRNewswire/ -- Pieris AG, a bio-pharmaceutical company developing Anticalins(R), a novel class of targeted human protein therapeutics, ...

Alexza Completes $10 Million Equity Financing with Bio*One Capital to Initiate Commercial Manufacturing in Singapore

Conference Call to be Held on Thursday, March 27, 2008 (7:00 p.m. Singapore Time and 7:00 a.m. Eastern Time) SINGAPORE and MOUNTAIN VIEW, Calif., March 26 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that Bio*One Capital Pte. Ltd., one of the la...

LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series 'C' Financing Round

BOZEMAN, Mont., March 18 /PRNewswire/ -- LigoCyte Pharmaceuticals, Inc., a vaccine company in Bozeman, Montana, announced that the company has successfully finalized an agreement for a $28 million venture capital financing round to further clinical development of its two lead vaccines against ...

Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments

Names Board of Directors SAN DIEGO, Jan. 31 /PRNewswire/ -- Sonexa Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapeutics for the treatment of Alzheimer's disease, announced today that it has raised $30 million in a Series A round of fina...